Ovarian cancer treatment could soon make use of a new scientific discovery, which has identified genes which may allow doctors to improve their prognosis and diagnosis techniques in the future.
A report from Duke University Medical Center found these genetic markers will allow individual subtypes of tumour to be recognised and lead to a more appropriate treatment for patients.
Cancer Research UK states that ovarian cancer is the fifth most common form of the disease among women in the UK, but improvements in treatment have lead to a survival rate which has almost doubled in the past 30 years.
This new study could help further improve that record, as prognosis methods for the most common causes of the disease are still relatively inaccurate.
Lead investigator Michael Datto, said: "This [work] raises the possibility that we have described molecular switch genes that will not only be relevant in the context of ovarian carcinoma, but across multiple tumour types."